JUN and nasopharyngeal carcinoma: Western blot analysis showed that treatment with a miR-3188 inhibitor increased expression of p-PI3K, p-AKT, c-JUN and CCND1, but reduced p27 and p21 levels in FOXO1-overexpressing NPC cells (Fig. 6e).